SERMONIX PHARMACEUTICALS Trademark

Trademark Overview

On Tuesday, November 5, 2019, a trademark application was filed for SERMONIX PHARMACEUTICALS with the United States Patent and Trademark Office. The USPTO has given the SERMONIX PHARMACEUTICALS trademark a serial number of 88681480. The federal status of this trademark filing is REGISTERED as of Tuesday, January 23, 2024. This trademark is owned by Sermonix Pharmaceuticals, Inc.. The SERMONIX PHARMACEUTICALS trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparation for post-menopausal women's health, namely, to prevent and treat breast cancer, osteoporosis and vulvovaginal atrophy
sermonix pharmaceuticals

General Information

Serial Number88681480
Word MarkSERMONIX PHARMACEUTICALS
Filing DateTuesday, November 5, 2019
Status700 - REGISTERED
Status DateTuesday, January 23, 2024
Registration Number7287506
Registration DateTuesday, January 23, 2024
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, October 13, 2020

Trademark Statements

Description of MarkThe mark consists of a series of nine circles in a vertical line next to a vertical line with another vertical line intersecting at the center, with a circle above, forming a geometric human figure, followed by the wording "SERMONIX PHARMACEUTICALS"
Goods and ServicesPharmaceutical preparation for post-menopausal women's health, namely, to prevent and treat breast cancer, osteoporosis and vulvovaginal atrophy
Indication of Colors claimedColor is not claimed as a feature of the mark.
Disclaimer with Predetermined Text"PHARMACEUTICALS"

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, November 13, 2019
Primary Code005
First Use Anywhere DateTuesday, June 20, 2023
First Use In Commerce DateTuesday, June 20, 2023

Trademark Owner History

Party NameSermonix Pharmaceuticals, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressColumbus, OH 43215
Party NameSermonix Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressColumbus, OH 43215
Party NameSermonix Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressColumbus, OH 43209

Trademark Events

Event DateEvent Description
Tuesday, January 23, 2024NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, January 23, 2024REGISTERED-PRINCIPAL REGISTER
Tuesday, December 19, 2023NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Saturday, December 16, 2023ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Friday, November 17, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, November 16, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, November 16, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, August 28, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, August 28, 2023NON-FINAL ACTION E-MAILED
Monday, August 28, 2023SU - NON-FINAL ACTION - WRITTEN
Saturday, July 22, 2023STATEMENT OF USE PROCESSING COMPLETE
Monday, July 17, 2023USE AMENDMENT FILED
Monday, July 17, 2023TEAS STATEMENT OF USE RECEIVED
Saturday, June 10, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, June 9, 2023SOU EXTENSION 5 GRANTED
Wednesday, May 31, 2023SOU EXTENSION 5 FILED
Friday, June 9, 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, May 31, 2023SOU TEAS EXTENSION RECEIVED
Tuesday, January 17, 2023ASSIGNED TO EXAMINER
Saturday, October 15, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, October 13, 2022SOU EXTENSION 4 GRANTED
Thursday, October 13, 2022SOU EXTENSION 4 FILED
Thursday, October 13, 2022SOU TEAS EXTENSION RECEIVED
Tuesday, October 11, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, October 11, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, October 11, 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
Friday, April 29, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, April 27, 2022SOU EXTENSION 3 GRANTED
Wednesday, April 27, 2022SOU EXTENSION 3 FILED
Wednesday, April 27, 2022SOU TEAS EXTENSION RECEIVED
Saturday, December 4, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, December 2, 2021SOU EXTENSION 2 GRANTED
Thursday, December 2, 2021SOU EXTENSION 2 FILED
Thursday, December 2, 2021SOU TEAS EXTENSION RECEIVED
Tuesday, June 8, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, June 4, 2021SOU EXTENSION 1 GRANTED
Friday, June 4, 2021SOU EXTENSION 1 FILED
Friday, June 4, 2021SOU TEAS EXTENSION RECEIVED
Tuesday, December 8, 2020NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, October 13, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 13, 2020PUBLISHED FOR OPPOSITION
Wednesday, September 23, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, September 8, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Sunday, September 6, 2020EXAMINER'S AMENDMENT ENTERED
Sunday, September 6, 2020NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Sunday, September 6, 2020EXAMINERS AMENDMENT E-MAILED
Sunday, September 6, 2020EXAMINERS AMENDMENT -WRITTEN
Wednesday, September 2, 2020PREVIOUS ALLOWANCE COUNT WITHDRAWN
Tuesday, August 25, 2020WITHDRAWN FROM PUB - OG REVIEW QUERY
Saturday, August 8, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, August 6, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, August 5, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, August 5, 2020TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sunday, February 16, 2020NOTIFICATION OF NON-FINAL ACTION E-MAILED
Sunday, February 16, 2020NON-FINAL ACTION E-MAILED
Sunday, February 16, 2020NON-FINAL ACTION WRITTEN
Sunday, February 9, 2020ASSIGNED TO EXAMINER
Thursday, November 14, 2019NOTICE OF DESIGN SEARCH CODE E-MAILED
Wednesday, November 13, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, November 8, 2019NEW APPLICATION ENTERED

Related Keywords

pharmaceuticals sermonix breast treat cancer osteoporosis atrophy vulvovaginal prevent namely post preparation